金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300434 金石亚药

已收盘 11-05 15:00:00

{"stockData":{"symbol":"300434","market":"SZ","secType":"STK","nameCN":"金石亚药","latestPrice":8.97,"timestamp":1730790222000,"preClose":8.85,"halted":0,"volume":5845940,"delay":0,"floatShares":342000000,"shares":401999999,"eps":0.1134,"marketStatus":"已收盘","marketStatusCode":5,"change":0.12,"latestTime":"11-05 15:00:00","open":8.94,"high":9.02,"low":8.83,"amount":52218000,"amplitude":0.0215,"askPrice":8.97,"askSize":523,"bidPrice":8.96,"bidSize":436,"shortable":0,"etf":0,"ttmEps":0.1134,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730856600000},"adr":0,"adjPreClose":8.85,"symbolType":"stock","openAndCloseTimeList":[[1730770200000,1730777400000],[1730782800000,1730790000000]],"highLimit":9.74,"lowLimit":7.97,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401743872,"pbRate":1.47,"roa":"--","roe":"2.39%","epsLYR":0.31,"committee":0.003375,"marketValue":3604000000,"floatMarketCap":3069000000,"peRate":79.100531,"changeRate":0.0136,"turnoverRate":0.0171,"status":0},"requestUrl":"/m/hq/s/300434","defaultTab":"news","newsList":[{"id":"2479218202","title":"金石亚药最新公告：全资子公司获得磷酸奥司他韦胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2479218202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479218202?lang=zh_cn&edition=full","pubTime":"2024-10-30 16:19","pubTimestamp":1730276370,"startTime":"0","endTime":"0","summary":"金石亚药公告，公司全资子公司亚洲制药收到国家药监局核准签发的《药品注册证书》。药品名称为磷酸奥司他韦胶囊，适应症为用于成人和1岁及1岁以上儿童的甲型和乙型流感治疗，以及用于成人和13岁及13岁以上青少年的甲型和乙型流感的预防。该产品的获批进一步丰富了公司的产品线，对公司未来业绩的提升将产生一定的积极影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000028416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"gpt_icon":0},{"id":"2478692005","title":"金石亚药（300434）2024年三季报简析：净利润减58.11%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2478692005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478692005?lang=zh_cn&edition=full","pubTime":"2024-10-25 06:07","pubTimestamp":1729807668,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金石亚药发布2024年三季报。截至本报告期末，公司营业总收入7.57亿元，同比下降8.51%，归母净利润5812.91万元，同比下降58.11%。按单季度数据看，第三季度营业总收入2.35亿元，同比上升21.4%，第三季度归母净利润1892.68万元，同比上升211.68%。本报告期金石亚药盈利能力上升，毛利率同比增幅12.54%，净利率同比增幅62.99%。去年的净利率为9.98%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500005257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"gpt_icon":0},{"id":"2477727559","title":"图解金石亚药三季报：第三季度单季净利润同比增211.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477727559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477727559?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:34","pubTimestamp":1729701279,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药2024年三季报显示，公司主营收入7.57亿元，同比下降8.51%；归母净利润5812.91万元，同比下降58.11%；扣非净利润5204.14万元，同比下降60.52%；其中2024年第三季度，公司单季度主营收入2.35亿元，同比上升21.4%；单季度归母净利润1892.68万元，同比上升211.68%；单季度扣非净利润1500.5万元，同比上升184.2%；负债率14.04%，投资收益-803.03万元，财务费用-199.3万元，毛利率55.38%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400000223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"gpt_icon":0},{"id":"2477081613","title":"金石亚药(300434.SZ)发布前三季度业绩，净利润5812.91万元，同比下降58.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477081613","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477081613?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:10","pubTimestamp":1729674627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)发布2024年第三季度报告，公司前三季度营业收入7.57亿元，同比下降8.51%;归属于上市公司股东的净利润5812.91万元，同比下降58.11%;归属于上市公司股东的扣除非经常性损益的净利润5204.14万元，同比下降60.52%;基本每股收益0.14元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300434"],"gpt_icon":0},{"id":"2464276824","title":"9月3日金石亚药现1笔折价21.57%的大宗交易 合计成交678万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464276824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464276824?lang=zh_cn&edition=full","pubTime":"2024-09-03 16:52","pubTimestamp":1725353573,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日金石亚药发生大宗交易，交易数据如下：大宗交易成交价格6元，相对当日收盘价折价21.57%，成交113万股，成交金额678万元，买方营业部为海通证券股份有限公司成都天府二街证券营业部，卖方营业部为海通证券股份有限公司成都天府二街证券营业部。近三个月该股共发生5笔大宗交易，合计成交6.6万手，折价成交5笔。该股近期无解禁股上市。截至2024年9月3日收盘，金石亚药(300434)报收于7.65元，上涨3.66%，换手率4.03%，成交量13.78万手，成交额1.05亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300026457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300434"],"gpt_icon":0},{"id":"2463425223","title":"A股医药股震荡走低，兴齐眼药跌超15%，普利制药跌逾10%，金石亚药、海辰药业、亚太药业、同和药业等跌幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2463425223","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463425223?lang=zh_cn&edition=full","pubTime":"2024-08-29 09:41","pubTimestamp":1724895668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0132","300434","300584","159938","300636","399300","BK0077","09939","BK0028","BK0239","300573","300630","BK1161","159982","BK1515","BK1574","002370","BK0177"],"gpt_icon":0},{"id":"2462431857","title":"图解金石亚药中报：第二季度单季净利润同比减512.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462431857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462431857?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:29","pubTimestamp":1724837386,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药2024年中报显示，公司主营收入5.22亿元，同比下降17.64%；归母净利润3920.22万元，同比下降74.83%；扣非净利润3703.64万元，同比下降75.25%；其中2024年第二季度，公司单季度主营收入1.59亿元，同比下降25.61%；单季度归母净利润-5061.4万元，同比下降512.5%；单季度扣非净利润-5060.75万元，同比下降592.02%；负债率13.94%，投资收益-547.96万元，财务费用-229.9万元，毛利率56.86%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800033179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"gpt_icon":0},{"id":"2462543633","title":"金石亚药(300434.SZ)发布上半年业绩，净利润3920.22万元，下降74.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462543633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462543633?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:09","pubTimestamp":1724836147,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)发布2024年半年度报告，该公司营业收入为5.22亿元，同比减少17.64%。归属于上市公司股东的净利润为3920.22万元，同比减少74.83%。归属于上市公司股东的扣除非经常性损益的净利润为3703.64万元，同比减少75.25%。基本每股收益为0.0976元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1173157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300434"],"gpt_icon":0},{"id":"2462645433","title":"8月28日金石亚药现1笔折价20.66%的大宗交易 合计成交679.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462645433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462645433?lang=zh_cn&edition=full","pubTime":"2024-08-28 16:40","pubTimestamp":1724834437,"startTime":"0","endTime":"0","summary":"证券之星消息，8月28日金石亚药发生大宗交易，交易数据如下：大宗交易成交价格5.76元，相对当日收盘价折价20.66%，成交118万股，成交金额679.68万元，买方营业部为海通证券股份有限公司成都天府二街证券营业部，卖方营业部为海通证券股份有限公司成都天府二街证券营业部。近三个月该股共发生4笔大宗交易，合计成交5.47万手，折价成交4笔。截至2024年8月28日收盘，金石亚药报收于7.26元，上涨0.83%，换手率0.81%，成交量2.71万手，成交额1968.11万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800029831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300434","BK0077","BK0239"],"gpt_icon":0},{"id":"2460939024","title":"8月20日金石亚药现2笔折价17.81%的大宗交易 合计成交1686.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460939024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460939024?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:40","pubTimestamp":1724143246,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日金石亚药发生大宗交易，交易数据如下：近三个月该股共发生3笔大宗交易，合计成交4.29万手，折价成交3笔。该股近期无解禁股上市。截至2024年8月20日收盘，金石亚药(300434)报收于7.58元，下跌2.57%，换手率0.72%，成交量2.42万手，成交额1849.72万元。该股最近90天内无机构评级。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000026077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300434"],"gpt_icon":0},{"id":"2459418151","title":"8月14日金石亚药现1笔折价18.94%的大宗交易 合计成交995.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459418151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459418151?lang=zh_cn&edition=full","pubTime":"2024-08-14 16:40","pubTimestamp":1723624845,"startTime":"0","endTime":"0","summary":"证券之星消息，8月14日金石亚药发生大宗交易，交易数据如下：大宗交易成交价格6.29元，相对当日收盘价折价18.94%，成交158.19万股，成交金额995.02万元，买方营业部为海通证券股份有限公司成都天府二街证券营业部，卖方营业部为海通证券股份有限公司成都天府二街证券营业部。近三个月该股共发生1笔大宗交易，合计成交1.58万手，折价成交1笔。截至2024年8月14日收盘，金石亚药报收于7.76元，下跌1.27%，换手率1.05%，成交量3.5万手，成交额2722.45万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400034076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2457367183","title":"金石亚药：益今生胶囊项目目前正处于Ⅱ期临床研究阶段，总共需要进行Ⅲ期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2457367183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457367183?lang=zh_cn&edition=full","pubTime":"2024-08-08 18:02","pubTimestamp":1723111353,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)08月08日在投资者关系平台上答复投资者关心的问题。投资者：请问公司研发的一级新药益今生胶囊是否还在正常推进，有无进展金石亚药董秘：尊敬的投资者，您好！益今生胶囊项目目前正处于Ⅱ期临床研究阶段，总共需要进行Ⅲ期临床研究。在研项目如果有实质性进展，公司将会严格按照相关要求履行信息披露义务。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800035782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"gpt_icon":0},{"id":"2453177761","title":"金石亚药：公司目前暂无创新药研发或临床阶段研发项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2453177761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453177761?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:01","pubTimestamp":1721649689,"startTime":"0","endTime":"0","summary":"亚科中心产权100%由上市公司全资子公司亚克药业持有。领业医药重点布局皮肤健康领域，目前已有三十余款改良型新药和高端仿制药产品研发管线的布局。公司目前暂无创新药研发或临床阶段研发项目，感谢您的关注！公司目前经营状况平稳。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200028885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","159992","300434","06978","BK1574","BK1161","BK0028"],"gpt_icon":0},{"id":"2439557845","title":"金石亚药：我公司业务目前涉及医药健康板块和新材料及机械设备板块，暂不涉及低空经济领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2439557845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439557845?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:00","pubTimestamp":1716991240,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)05月29日在投资者关系平台上答复投资者关心的问题。投资者：各个地方支持发展低空经济，请问公司业务涉及低空经济领域吗金石亚药董秘：尊敬的投资者，您好！我公司业务目前涉及医药健康板块和新材料及机械设备板块，暂不涉及低空经济领域。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900043458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300434","159703"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-04-24","address":"四川省成都市双流区九江镇万家社区","stockEarnings":[{"period":"1week","weight":-0.0066},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.1649},{"period":"6month","weight":-0.0419},{"period":"1year","weight":-0.2459},{"period":"ytd","weight":-0.1771}],"companyName":"四川金石亚洲医药股份有限公司","boardCode":"AI0027","perCapita":"18316股","boardName":"医药制造业","registeredCapital":"40174万元","compareEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1802},{"period":"6month","weight":0.0738},{"period":"1year","weight":0.1074},{"period":"ytd","weight":0.1385}],"survey":"　　四川金石亚洲医药股份有限公司主营业务为医药健康和新材料与机械两个板块。公司主要产品包括成套生产线、机械配件及其他、保健品、快克等。快克产品自上世纪90年代推出，经过多年发展，“快克”系列感冒药已经成为国内家喻户晓的品牌，在感冒药领域具备较高知名度，产品及品牌竞争优势显著，并获得国家“驰名商标”的荣誉。","serverTime":1730852356757,"listedPrice":10.57,"stockholders":"18678人(较上一季度减少5.40%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金石亚药,300434,金石亚药股票,金石亚药股票老虎,金石亚药股票老虎国际,金石亚药行情,金石亚药股票行情,金石亚药股价,金石亚药股市,金石亚药股票价格,金石亚药股票交易,金石亚药股票购买,金石亚药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}